Research Brings Knowledge, Knowledge Brings Answers, Answers Bring Hope
This is an important time for Alzheimer’s research.
For the first time in history, Congress voted to overwhelmingly pass the 2016 omnibus spending bill that includes $350 million in new dollars for Alzheimer’s research, a 60 percent increase over the 2015 budget. This funding breakthrough sets the stage for more important research studies to be conducted.
Because of this historic government support together with the national scientific community’s ever-expanding understanding of this disease and the ongoing development of more effective tools to help us diagnosis the disease earlier, we believe that we are on a pathway to delay, cure and ultimately prevent Alzheimer’s disease and other related dementias.
These discoveries and advances are ONLY possible because of countless people across the country, throughout North Carolina and right here in Winston-Salem, who have made the decision to get involved in Alzheimer’s research and become part of the cure.
Through these clinical trials and observational studies, we are able to learn more about the disease and test the effectiveness and safety of innovative treatments. Throughout all of our clinical trials and research studies, the safety and welfare of our research volunteers is first and always our top priority.
We conduct two types of clinical research:
Clinical Trials evaluate the effectiveness of various interventions, such as new medications or lifestyle modifications. Throughout the research community, clinical trials are the primary way for scientists to discover if a new treatment or other interventions are safe and effective.
Observational Studies assess and follow groups of people in their normal, everyday life over time. By following these groups, researchers are able to gather information to help understand who is at risk and why.